CALL - SPRINTER OPEN END - STRYKER CORP. Stock

Certificat

DE000VM55FR3

Delayed Deutsche Boerse AG 11:05:19 2024-06-27 am EDT
15.39 EUR +0.46% Intraday chart for CALL - SPRINTER OPEN END - STRYKER CORP.
Current month+1.66%
1 month+3.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-27 15.39 +0.46%
24-06-26 15.32 +2.07%
24-06-25 15.01 -2.60%
24-06-24 15.41 +0.72%
24-06-21 15.3 -0.78%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 11:05 am EDT

More quotes

Static data

Product typeWarrant Knock-Out senza Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55FR
ISINDE000VM55FR3
Date issued 2023-11-29
Strike 177.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 11.71
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.25
Lowest since issue 10.84
Spread 0.04
Spread %0.26%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.52%
Consensus